Grading system for lymph vessel tumor emboli: significant outcome predictor for invasive ductal carcinoma of the breast

Human Pathology

Volumn 41, Issue 5, 2010, Pages 706-715

  Hasebe, Takahiro ^a   Okada, Nao ^b   Iwasaki, Motoki ^c   Akashi Tanaka, Sadako ^b   Hojo, Takashi ^b   Shibata, Tatsuhiro ^d   Sasajima, Yuko ^b   Tsuda, Histoshi ^b   Kinoshita, Takayuki ^b  

^a Center for Cancer Control and Information Services   (Japan)

^b NATIONAL CANCER CENTER HOSPITAL   (Japan)

^c NATIONAL CANCER CENTER   (Japan)

^d NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

Author keywords

Breast cancer; Grade; Lymph vessel; p53; Prognosis

Indexed keywords

ANTHRACYCLINE; GONADORELIN AGONIST; PROTEIN P53; TAMOXIFEN;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER INVASION; CANCER MORTALITY; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; INTRADUCTAL CARCINOMA; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPH VESSEL; MAJOR CLINICAL STUDY; MASTECTOMY; PARTIAL MASTECTOMY; PROGNOSIS; PROTEIN EXPRESSION; TUMOR EMBOLISM; TUMOR RECURRENCE;

BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; FEMALE; HUMANS; KAPLAN-MEIERS ESTIMATE; LYMPHATIC METASTASIS; LYMPHATIC VESSELS; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; PROGNOSIS;

EID: 77950689246     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humpath.2009.10.015     Document Type: Article

References (37)

1. Lauria R., Perrone F., Carlomagno C., et al. The prognostic value of lymphatic and blood vessel invasion in operable breast cancer. Cancer 76 (1995) 1772-1778
2. Nime F.A., Rosen P.P., Tzvi Thaler H., et al. Prognostic significance of tumor emboli intramammary lymphatics in patients with mammary carcinoma. Am J Surg Pathol 1 (1977) 25-30
3. Hasebe T., Sasaki S., Imoto S., et al. Characteristics of tumors in lymph vessels play an important role in the tumor progression of invasive ductal carcinoma of the breast: a prospective study. Mod Pathol 15 (2002) 904-913
4. Hoshida T., Isaka N., Hagendoorn J., et al. Imaging steps of lymphatic metastasis reveals that vascular endothelial growth factor-C increases metastasis by increasing delivery of cancer cells to lymph nodes: therapeutic implications. Cancer Res 66 (2006) 8065-8075
5. Yamauchi C., Hasebe T., Iwasaki M., et al. Accurate assessment of lymph vessel tumor emboli in invasive ductal carcinoma of the breast according to tumor areas, and their prognostic significance. Hum Pathol 38 (2007) 247-259
6. Hasebe T., Yamauchi C., Iwasaki M., et al. Grading system for lymph vessel tumor emboli for prediction of the outcome of invasive ductal carcinoma of the breast. Hum Pathol 39 (2008) 427-436
7. Hasebe T., Okada N., Tamura N., et al. p53 expression in tumor-stromal fibroblasts is associated with the number of nodal metastasis and the outcome of patients with invasive ductal carcinoma independent of the breast. Cancer Sci 100 (2009) 2101-2108
8. Sobin L.H., and Wittekind C.H. Breast tumours (ICD-O C50). In: Sobin L.H., and Wittekind C.H. (Eds). TNM classification of malignant tumors. 6th ed. (2002), Wiley-Liss, Geneva 131-141
9. Bloom H.J.G., and Richardson W.W. Histological grading and prognosis in breast cancer. Br J Cancer 11 (1957) 359-377
10. Gilchrist K.W., Gray R., Fowble B., et al. Tumor necrosis is a prognostic predictor for early recurrence and death in lymph node-positive breast cancer: a 10-year follow-up study of 728 eastern cooperative oncology group patients. J Clin Oncol 11 (1993) 1929-1935
11. Hasebe T., Tsuda H., Hirohashi S., et al. Fibrotic focus in infiltrating ductal carcinoma of the breast: a significant histopathological prognostic parameter for predicting the long-term survival of the patients. Breast Cancer Res Treat 49 (1998) 195-208
12. Hasebe T., Sasaki S., Imoto S., et al. Prognostic significance of fibrotic focus in invasive ductal carcinoma of the breast: a prospective observational study. Mod Pathol 15 (2002) 502-516
13. Fukunaga M. Expression of D2-40 in lymphatic endothelium of normal tissues and in vascular tumours. Histopathology 46 (2005) 396-402
14. Niakosari F., Kahn H.J., Marks A., et al. Detection of lymphatic invasion in primary melanoma with monoclonal antibody D2-40: a new selective immunohistochemical marker of lymphatic endothelium. Arch Dermatol 141 (2005) 440-444
15. Allred D.C., Harvey J.M., Berardo M.D., et al. Prognostic and predictive factors in breast cancer by immunohistochemical analysis. Mod Pathol 11 (1998) 155-168
16. Harvey J.M., Clark G.M., Osborne K., et al. Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer. J Clin Oncol 17 (1999) 1474-1481
17. Mohsin S., Weiss H., Havighurst T., et al. Progesterone receptor by immunohistochemistry and clinical outcome in breast cancer: a validation study. Mod Pathol 17 (2004) 1545-1554
18. Badve S.S., Baehner F.L., Gray R.P., et al. Estrogen- and progesterone-receptor status in ECOG2197: comparison of immunohistochemistry by local and central laboratories and quantitative reverse transcription polymerase chain reaction by central laboratory. J Clin Oncol 26 (2008) 2473-2481
19. Allred D.C., Clark G.M., Elledge R., et al. Association of p53 protein expression with tumor cell proliferation rate and clinical outcome in node-negative breast cancer. J Natl Cancer Inst 85 (1993) 200-206
20. Wolff A.C., Hammond M.E., Schwartz J.N., et al. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. Arch Pathol Lab Med 131 (2007) 18-43
21. Cox D.R. Regression models and life-tables. J R Stat Soc 34 (1972) 187-220
22. Kaplan E.L., and Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 53 (1958) 457-481
23. Charles V.B., and William H. Apoptotic bodies: a consistent morphologic feature of endocervical adenocarcinoma in situ. Am J Surg Pathol 22 (1998) 434-439
24. Bishop E.F., Badve S., Morimiya A., et al. Apoptosis in spermatocytic and usual seminomas: a light microscopic and immunohistochemical study. Mod Pathol 20 (2007) 1036-1044
25. de Jong J.S., van Diest P.V., and Baak J.P.A. Number of apoptotic cells as a prognostic marker in invasive breast cancer. Br J Cancer 82 (2000) 368-373
26. Hill R., Song Y., Cardiff R.D., et al. Selective evolution of stromal mesenchyme with p53 loss in response to epithelial tumorigenesis. Cell 123 (2006) 1001-1011
27. Bierie B., and Moses H.L. Under pressure: stromal fibroblasts change their ways. Cell 123 (2005) 985-987
28. Moinfar F., Man Y.G., Arnould L., et al. Concurrent and independent genetic alterations in the stromal and epithelial cells of mammary carcinoma: implication for tumorigenesis. Cancer Res 60 (2000) 2562-2566
29. Patocs A., Zhang L, Xu Y., et al. Breast-cancer stromal cells with TP53 mutations and nodal metastases. N Engl J Med 357 (2007) 2543-2551
30. Kiaris H., Chatzistamou I., Trimis G., et al. Evidence for nonautonomous effect of p53 tumor suppressor in carcinogenesis. Cancer Res 65 (2005) 1627-1630
31. Allinen M., Beroukhim R., Cai L., et al. Molecular characterization of the tumor microenviroment in breast cancer. Cancer Cell 6 (2004) 17-32
32. Lebret S.C., Newgreen D.F., Thompson E.W., et al. Induction of epithelial to mesenchymal transition in PMC42-LA human breast carcinoma cells by carcinoma-associated fibroblast secreted factors. Breast Cancer Res 9 (2007) R19
33. Campbell I.G., Qiu W., Polyak K., et al. Breast-cancer stromal cells with TP53 mutations. N Engl J Med 10 (2008) 1634-1635
34. Westbrook L., Manuvakhova M., Kern F.G., et al. Cks1 regulates cdk1 expression: a novel role during mitotic entry in breast cancer cells. Cancer Res 67 (2007) 11393-11401
35. Nakamura Y., Tanaka F., Haraguchi N., et al. Clinicopathological and biological significance of mitotic centromere-associated kinesin overexpression in human gastric cancer. Br J Cancer 97 (2007) 543-549
36. Budhram-Mahadeo V.S., Irshad S., Bowen S., et al. Proliferation-associated Brn-3b transcription factor can activate cyclin D1 expression in neuroblastoma and breast cancer cells. Br J Cancer 27 (2008) 145-154
37. Xiao Y., Ye Y., Yearsley K., et al. The lymphovascular embolus of inflammatory breast cancer expresses a stem cell-like phenotype. Am J Pathol 173 (2008) 561-574